Human Papillomavirus May Trigger onset and progression of thyroid eye disease, reports research Jacinthlyn Sylvia8 May 2025 8:15 PM ISTA recent study from Bascom Palmer Eye Institute uncovered potential molecular evidence linking human papillomavirus (HPV) to thyroid eye disease...
Facial Photograph-Based AI Tool Promising in Thyroid Eye Disease Assessment: Study Shows Medha Baranwal12 April 2025 4:00 AM ISTSouth Korea: A recent study published in Ophthalmology Science has found that a deep learning (DL)-driven method for measuring proptosis in thyroid...
Linsitinib significantly improved proptosis among patients with thyroid eye disease, shows trial Dr. Kamal Kant Kohli19 Jan 2025 9:00 PM ISTTopline results have been announced from a Phase 2/3 trial assessing linsitinib for the treatment of active, moderate to severe thyroid eye disease...
Bilateral single orbital triamcinolone injections provided relief from Thyroid Eye Disease symptoms, reveals research Dr Ishan Kataria21 Nov 2024 8:45 PM ISTThyroid eye disease (TED) represents a prevalent type of orbital tissue inflammation associated with autoimmune disorders linked to thyroid...
Thyroid eye disease patients report maintained improvement 2 years after teprotumumab infusions, reveals research Dr. Kamal Kant Kohli26 Jun 2024 8:15 PM ISTMost patients with thyroid eye disease treated with teprotumumab didn't require additional treatments nearly 2 years later, according to...
Teprotumumab: A game-changer in thyroid eye disease treatment, treats across phenotypes, study finds Medha Baranwal14 May 2024 10:00 AM ISTUSA: In a groundbreaking development for patients suffering from thyroid eye disease (TED), recent clinical trials have demonstrated the remarkable...
Increased extraocular muscle volume tied to dysthyroid optic neuropathy in patients with thyroid eye disease Dr. Shravani Dali9 Jan 2024 9:15 AM ISTIncrease in extraocular muscle volume tied to dysthyroid optic neuropathy in patients with thyroid eye disease suggests a new study published in the...
Moderate to severe Thyroid eye disease associated with increasing severity of proptosis/diplopia Dr Ishan Kataria12 Jan 2023 8:00 PM ISTThyroid eye disease (TED) is an inflammatory autoimmune condition most often presenting with Graves disease. Those at risk for more severe disease...
Arched rainbow brow: A new clinical trait that can help diagnose thyroid eye disease Dr. Kamal Kant Kohli14 Oct 2022 4:15 AM ISTU.S.A: According to a study published in the journal Ophthalmic Plastic & Reconstructive Surgery, the rainbow brow is a novel clinical...
Novel anti-IGF-1R antibody promising treatment for Thyroid Eye Disease in clinical trial Dr. Kamal Kant Kohli22 Aug 2022 3:30 PM ISTAn anti-IGF-1R antibody VRDN-001developed by Viridian Therapeutics has succeeded in a phase I/II clinical trial of people with active thyroid eye...
Teprotumumab- a novel treatment for pretibial myxedema Dr Manoj Kumar Nayak30 Jun 2022 11:00 AM ISTTeprotumumab- a novel treatment for pretibial myxedema Pretibial myxedema (PTM) is an unusual extrathyroidal manifestation of autoimmune thyroid...
Hearing loss serious concern with respect to use of Teprotumumab in Thyroid Eye Disease Medical Dialogues Editorial Team28 March 2022 9:00 AM ISTIn a new study conducted by Connie M. Sears and team found that hearing loss is a worrisome side effect of teprotumumab. The findings of this study...
